Abstract
This report begins with a summary of the evidence for genetic involvement in certain major psychiatric syndromes. The relation of these disorders to deficits in central nervous system neurotransmitters is also summarized. These reviews serve as an introduction to our studies on the genetic regulation of neurotransmitters and their enzymes and receptors in inbred mice. The steady-state levels of the adrenal catecholamine biosynthetic enzymes are controlled genetically; not only is each enzyme regulated by a single locus, but also there is statistical evidence that the phenotypic expression of the entire pathway is regulated by a single gene. Studies on the biochemical mechanism of gene action suggest that genetic regulation is exerted on proteolysis of the enzymes, rather than their synthesis. In addition, we have examined the genetic control of dopamine receptors in inbred mice. Dopaminergic receptors in the nigrostriatal and mesolimbic pathways are under genetic control. Preliminary evidence suggests that the pathways are regulated by different genetic systems. If this early speculation proves true, it would have important clinical implications.
Similar content being viewed by others
References
Anden, N. E. (1974). Antipsychotic drugs and catecholamine synapses.J. Psychiat. Res. 11:97–104.
Anden, N. E., Carlsson, A., and Haggendal, J. (1969). Adrenergic mechanisms.Annu. Rev. Pharmacol. 9:119–134.
Andrews, C. D., Davis, A., Freeman, H. S., McDermed, J. D., Poat, J. A., and Woodruff, N. (1978). Effects of the (+) and (−)-enantiomers of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene on dopamine receptors and on dopamine uptake.Br. J. Pharmacol. 64:1–433.
Angrist, B., and Gershon, S. (1977). Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects.Adv. Biochem. Psychopharmacol. 16:667–680.
Angst, J., and Perris, C. (1968). Zur Nosologie endogener Depressionen. Vergleich der Ergebneisse zweier Untersuchungen.Arch. Psychiat. Z. Neurol. 210:373–386.
Bender, L. (1974). The family patterns of 100 schizophrenic children observed at Bellevue, 1935–1952.J. Aut. Child. Schiz. 4:279–292.
Bender, L. (1975). Schizophrenic spectrum disorders in the families of schizophrenic children. In Fieve, R. R., Rosenthal, D., and Brill, H. (eds.),Genetic Research in Psychiatry, Johns Hopkins University Press, Baltimore, pp. 125–145.
Bunney, W. E., Jr., and Davis, J. M. (1965) Norepinephrine in depressive reactions.Arch. Gen. Psychiat. 13:483–494.
Burt, D. B., Creese, I., and Snyder, S. H. (1977). Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain.Science 196:326–328.
Carlsson, A., and Lindqvist, M. (1963). Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain.Acta Pharmacol. (Koh) 20:140–144.
Ciaranello, R. D. (1977). Genetic regulation of the catecholamine synthesizing enzymes: Relationships to behavior and psychiatric disturbances. In Fields, W. S. (ed.)Neurotransmitter Function, Stratton, New York, pp. 281–304.
Ciaranello, R. D., and Axelrod, J. (1973). Genetically controlled alterations in the rate of degradation of phenylethanolamine N-methyltransferase.J. Biol Chem. 248:5616–5623.
Ciaranello, R. D., Barchas, R., and Kessler, S. (1972a). Catecholamines: Strain differences in biosynthetic enzyme activity in mice.Life Sci. 11:565–572.
Ciaranello, R. D., Dornbusch, J. N., and Barchas, J. D. (1972b). Regulation of adrenal phenylethanolamine N-methyltransferase in three inbred mouse strains.Mol. Pharmacol. 8:511–519.
Ciaranello, R. D., Hoffman, H., Schire, J. G. M., and Axelrod, J. (1974). Genetic regulation of the catecholamine biosynthetic enzymes.J. Biol. Chem. 249:4528–4534.
Clow, A., Jenner, P., Theodorou, A., and Marsden, C. D. (1978). Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months.Nature 278:59–61.
Connell, P. H. (1958).Amphetamine Psychosis, Chapman and Hall, London.
Cooper, D. O., and Stolk, J. M. (1979). Differences between inbred rat strains in the alteration of adrenal catecholamine synthesizing enzyme activities after immobilization stress.Neuroscience 4:1063–1072.
Creese, I., Burt, D. B., and Snyder, S. H. (1975). Dopamine receptor binding: Differentiation of agonist and antagonist state with3H-dopamine and3H-haloperidol.Life Sci. 17:993–1002.
Creese, I., Burt, D. R., and Snyder, S. H. (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.Science 192:481–483.
Creese, I., Prosser, T., and Snyder, S. H. (1978). Dopamine receptor binding: Specificity, localization and regulation by ions and guanyl nucleotiddes.Life Sci. 23:495–500.
Crow, T. J., Johnstone, E. C., Longden, A. J., and Owen, F. (1978). Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease process.Life Sci. 23:563–568.
Crowe, R. (1975) An adoptive study of psychopathy: Preliminary results from arrest records and psychiatric hospital records. In Fieve, R. R., Rosenthal, D., and Brill, H. (eds.),Genetic Research in Psychiatry, Johns Hopkins University Press, Baltimore, pp. 95–104.
DiChiarra, G., Corsini, G. U., Mereu, G. P., Tissari, A., and Gessa, G. L. (1978). Self-inhibitory dopamine receptors: Their role in the biochemical and behavioral effects of low doses of apomorphine.Adv. Biochem. Psychopharmacol. 19:275–292.
Enna, S. H., Bennett, J. P., Jr., Burt, D. R., Creese, I., and Snyder, S. H. (1976). Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.Nature 263:338–341.
Falconer, D. S. (1963). Quantitative genetics. In Burdette, W. J. (ed.),Methodology in Mammalian Genetics, Holden Day, San Francisco, p. 215.
Folstein, S., and Rutter, M. (1978). A twin study of individuals with infantile autism. In Rutter, M., and Scholpler, E. (eds.),Autism: A Reappraisal of Concepts and Treatment, Plenum Press, New York, pp. 219–242.
Furchgott, R. F. (1978). Pharmacological characterization of receptors: Its relation to radioligand-binding studies.Fed. Proc.,37:115–120.
Hanson, D. R., and Gottesman, I. (1976). The genetics, if any, of infantile autism and childhood schizophrenia.J. Aut. Child. Schiz. 6:209–234.
Hoffman, H., and Ciaranello, R. D. (1974). Genetic regulation of the catecholamine biosynthetic enzymes: Statistical appendix.J. Biol. Chem. 249:4535–4536.
Howlett, D. R., Morris, H., and Nahorski, S. R. (1979). Anomalous properties of3H-spiperone binding sites in various areas of the rat limbic system.Mol. Pharmacol. 15:506–514.
Hyttel, J. (1978a). A comparison of the effect of neuroleptic drugs on the binding of3H-haloperidol and3H-cis(z)-flupenthioxol and on adenylate cyclase activity in rat striatal tissuein vitro.Prog. Neuro-Psychopharmacol. 2:329–335.
Hyttel, J. (1978b). Effects of neuroleptics on3H-haloperidol and3H-cis(z)-flupenthioxol binding and on adenylate cyclase activityin vitro.Life Sci. 23:551–556.
Kebabian, J. W., and Calne, D. B. (1979). Multiple receptors for dopamine.Nature 277:93–96.
Kessler, S., Ciaranello, R. D., Shire, J. G. M., and Barchas, J. D. (1971). Genetic variation in catecholamine synthesizing enzyme activities.Genetics 68 (Suppl.):33 (abstr.).
Kessler, S., Ciaranello, R. D., Shire, J. G. M., and Axelrod, J. (1972). Genetic variation in activity of enzymes involved in synthesis of catecholamines.Proc. Natl. Acad. Sci. USA 69:2448–2450.
Kety, S. S., Rosenthal, D., Wender, P. H., Schulsinger, F., and Jacobsen, B. (1975). Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: A preliminary report based on psychiatric interviews. In Fieve, R. R., Rosenthal, D., and Brill, H., (eds.),Genetic Research in Psychiatry, Johns Hopkins University Press, Baltimore, pp. 147–166.
Laduron, P. (1976). Limiting factors in the antagonism of neuroleptics on dopamine-sensitive adenylate cyclase.J. Pharm. Pharmacol. 28:250–251.
Leysen, J. E., and Gommeren, W. (1978). Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex.Life Sci. 23:447–452.
Mendlewicz, J., and Fleiss, J. L. (1974). Linkage studies with x-chromosome markers in bipolar (manic-depressive) and unipolar (depressive) illnesses.Biol. Psychiat. 9:261–294.
Mendlewicz, J., Fleiss, J. L., and Fieve, R. R. (1975). Linkage studies in affective disorders: The Xg blood group and manic-depressive illness. In Fieve, R. R., Rosenthal, D., and Brill, H. (eds.),Genetic Research in Psychiatry, Johns Hopkins University Press, Baltimore, pp. 219–232.
Miller, R. J., and Hilley, C. R. (1974). Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism.Nature 248:596–597.
Norcross, K., and Spehlmann, R. (1978). A quantitative analysis of the excitatory and depressant effects of dopamine on the firing of caudatal neurons: Electrophysiological support for the existence of two distinct dopamine-sensitive receptors.Brain Res. 156:168–174.
Ogren, S. O., Hall, H., and Kohler, C. (1978). Studies on the stereoselective dopamine receptor blockade in the rat brain by rigid spiro amines.Life Sci. 23:1769–1774.
Paigen, K. (1971).The genetics of enzyme realization. In Rechcigl, M. (ed.),Enzyme Synthesis and Degradation in Mammalian Systems, S. Karger, Basel, pp. 1–40.
Peroutka, S., and Snyder, S. H. (1979). Multiple serotonin receptors: Differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.Mol. Pharmacol. 16:687–699.
Reich, T., Clayton, P. J., and Winokur, G. (1969). Family history studies. V. The genetics of mania.Am. J. Psychiat. 125:1358–1369.
Reich, T., Winokur, G., and Mullaney, J. (1975). The transmission of alcholism. In Fieve, R. R., Rosenthal, D., and Brill, H. (eds.),Genetic Research in Psychiatry, Johns Hopkins University Press, Baltimore, pp. 259–271.
Reis, D. J., Baker, H., Fink, S., and Joh, T. H. (1978). A genetic control of the number of central dopamine neurons in relationship to brain organization, drug responses, and behavior. In Usdin, E., Kopin, I. J., and Barchas, J. D. (eds.),Catecholamines: Basic and Clinical Frontiers, Pergamon Press, New York, pp. 23–33.
Rosanoff, A. J., Handy, L. M., and Plesset, I. R. (1935). The etiology of manic-depressive syndromes with special reference to their occurrence in twins.Am. J. Psychiat. 91:725–762.
Rosenthal, D., and Kety, S. S. (eds.) (1968).The Transmission of Schizophrenia, Pergamon, Oxford.
Rutter, M., and Bartak, L. (1971). Causes of infantile autism: Some considerations from recent research.J. Aut. Child. Schiz. 1:20–32.
Scheel-Kruger, J., and Randrup, A. (1967). Stereotype hyperactive behavior produced by dopamine in the absence of noradrenaline.Life Sci. 6:1389–1391.
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: A review of supporting evidence.Am. J. Psychiat. 122:509–522.
Schildkraut, J. J., and Kety, S. (1967). Biogenic amines and emotion.Science 156:21–30.
Schwartz, J. C., Baudry, M., Martres, M. P., Contentin, J., and Protais, P. (1978). Increasedin vivo binding of H-3-pimozide in mouse striatum following repeated administration of haloperidol.Life Sci. 23:1786–1790.
Seeman, P., Lee, T., Chau-Wong, M., Tedesco, J., and Wong, K. (1976). Dopamine receptors in human and calf brains, using3H-apomorphine and an antischizophrenic drug.Proc. Natl. Acad. Sci. USA 73:4354–4358.
Seeman, P., Titeler, M., Tedesco, J., Weinreich, P., and Sinclair, D. (1978). Brain receptors for dopamine and neuroleptics.Adv. Biochem. Psychopharmacol. 19:167–176.
Seeman, P., Westman, K., Protiva, M., Jilek, J., Jain, P. C., Saxena, A. K., Anank, N., Humber, L., and Philipp, A. (1979). Neuroleptic receptors: Stereoselectivity for neuroleptic enantiomers.Eur. J. Pharmacol. 56:247–252.
Slater, R. (1936). The inheritance of manic-depressive insanity.Proc. R. Soc. Med. 29:981–990.
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., and Greenberg, D. A. (1974). Drugs, neurotransmitters, and schizophrenia.Science 184:1243–1253.
Spano, P. F., Govoni, S., and Trabucchi, M. (1978). Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.Adv. Biochem. Psychopharmacol. 19:155–166.
Stawarz, R. J., Hill, H., Robinson, S. E., Setler, P., Dingell, J. V., and Sulser, F. (1975). On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain.Psychopharmacologia 43:125–130.
Steward, J. (1969). Biometrical genetics with one or two loci. I. The choice of a specific genetic model.Heredity (London) 24:211–224.
Stolk, J. M., Cooper, D. O., Hurst, J. H., Ledbetter, M. S., and Harris, P. Q. (1978). Strainspecific mechanisms regulating adrenal catecholamine synthesizing enzymes during repeated immobilization stress. In Usdin, E., Kopin, I. J., and Barchas, J. D. (eds.),Catecholamines: Basic and Clinical Frontiers, Pergamon Press, New York, pp. 1684–1686.
VonGreiff, H., McHugh, P. R., and Stokes, P. R. (1975). The familial history in sixteen males with bipolar manic-depressive illness. In Fieve, R. R., Rosenthal, D., and Brill, H. (eds.),Genetic Research in Psychiatry, Johns Hopkins University Press, Baltimore, pp. 233–239.
Wilk, S., Watson, E., and Stanley, M. E. (1975). Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.J. Pharmacol. Exp. Ther. 195:265–270.
Winokur, G., and Clayton, P. J. (1967). Family history studies. I. Two types of affective disorders separated according to genetic and clinical factors. In Wortes, J. (ed.),Recent Advances in Biology and Psychiatry, Vol. 9, Plenum Press, New York, pp. 35–50.
Wolfe, B. B., Harden, T. K., Sporn, J. R., and Moninoff, P. B. (1978). Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants.J. Pharmacol. Exp. Ther. 207:446–457.
Wong, D. L., Masover, S. J., and Ciaranello, R. D. (1981). Regulation of dopamine β-hydroxylase synthesis and degradation. Ascorbic acid stabilization of the enzyme against tryptic proteolysis.J. Biol. Chem. 256:695–700.
Author information
Authors and Affiliations
Additional information
These studies were supported by funds from the National Institutes of Health (MH-25998, MH and RR-5353), the National Science Foundation (PCM 78-14183 and PCM 80-11525), the Weingart Foundation, and the Scottish Rite Foundation. R.D.C. is the recipient of Research Scientist Development Award MH-00219.
Rights and permissions
About this article
Cite this article
Ciaranello, R.D., Boehme, R.E. Genetic regulation of neurotransmitter enzymes and receptors: Relationship to the inheritance of psychiatric disorders. Behav Genet 12, 11–35 (1982). https://doi.org/10.1007/BF01065738
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01065738